We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Bread Financial
BFH
$4.21B
| $2.08M | 0.02% |
11,741
+6,075
| +107% | +$1.13M |
|
552
Markel Group
MKL
$25B
| $2.06M | 0.02% |
1,930
-77
| -4% | -$79.6K |
|
553
Eversource Energy
ES
$28.2B
| $2.05M | 0.02% |
33,908
+4,608
| +16% | +$284K |
|
|
PTLA
554
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.04M | 0.02% |
37,783
+2,935
| +8% | +$172K |
|
555
Universal Health Services
UHS
$9.43B
| $2.03M | 0.02% |
18,337
+1,220
| +7% | +$137K |
|
556
Synopsys
SNPS
$71.5B
| $2.03M | 0.02% |
25,209
+1,339
| +6% | +$104K |
|
557
Fortive
FTV
$19B
| $2.02M | 0.02% |
45,347
-37,872
| -46% | -$1.58M |
|
|
ONCE
558
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2M | 0.02% |
22,402
+4,370
| +24% | +$332K |
|
|
COL
559
DELISTED
Rockwell Collins
COL
| $1.99M | 0.02% |
15,232
+2,051
| +16% | +$249K |
|
560
Dollar General
DG
$25.9B
| $1.99M | 0.02% |
24,557
+4,065
| +20% | +$305K |
|
|
PARA
561
DELISTED
Paramount Global Class B
PARA
| $1.99M | 0.02% |
34,313
+4,386
| +15% | +$277K |
|
562
ProShares Global Listed Private Equity ETF
PEX
$11.2M
| $1.99M | 0.02% |
47,051
+3,477
| +8% | +$148K |
|
|
SIVB
563
DELISTED
SVB Financial Group
SIVB
| $1.99M | 0.02% |
10,614
-1,634
| -13% | -$287K |
|
564
AGNC Investment
AGNC
$12.3B
| $1.97M | 0.02% |
90,857
-4,235
| -4% | -$90.5K |
|
565
Lumen
LUMN
$6.53B
| $1.97M | 0.02% |
104,175
+4,682
| +5% | +$98.6K |
|
|
IPG
566
DELISTED
Interpublic Group of Companies
IPG
| $1.97M | 0.02% |
94,552
+3,856
| +4% | +$83.9K |
|
|
JNPR
567
DELISTED
Juniper Networks
JNPR
| $1.97M | 0.02% |
70,627
+3,033
| +4% | +$84.9K |
|
568
Campbell Soup
CPB
$6.51B
| $1.95M | 0.02% |
41,638
-2,267
| -5% | -$115K |
|
569
Newell Brands
NWL
$2.16B
| $1.94M | 0.02% |
45,403
-39,107
| -46% | -$1.91M |
|
570
EQT Corp
EQT
$33.2B
| $1.93M | 0.02% |
54,344
+1,422
| +3% | +$48.3K |
|
571
Ligand Pharmaceuticals
LGND
$6.02B
| $1.93M | 0.02% |
22,715
+1,442
| +7% | +$114K |
|
|
AVXS
572
DELISTED
AveXis, Inc. Common Stock
AVXS
| $1.91M | 0.02% |
19,699
+3,272
| +20% | +$295K |
|
|
VER
573
DELISTED
VEREIT, Inc.
VER
| $1.89M | 0.02% |
45,564
-6,393
| -12% | -$270K |
|
574
Agios Pharmaceuticals
AGIO
$2.16B
| $1.89M | 0.02% |
28,244
+2,621
| +10% | +$157K |
|
575
Quest Diagnostics
DGX
$25.1B
| $1.88M | 0.02% |
20,120
+2,042
| +11% | +$217K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.